Pharmaniaga rises to five-month high on positive vaccine business outlook

Pharmaniaga Bhd rose as much as 43 sen or 8.5% to a more than five-month high of RM5.49 as investors got more positive on the group’s vaccine business outlook amid a spike in Covid-19 cases.